Related Experiment Video
Updated: Jun 21, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Practical aspects of assessing toxicokinetics and toxicodynamics
D E Johnson1, R A Braeckman, G H Wolfgang
1Chiron Corporation, Emeryville, CA 94608-2916, USA. dale_johnson@cc.chiron.com
Developing robust toxicokinetics and toxicodynamics (TK/TD) knowledge is crucial for effective high-throughput screening in drug development. This review outlines optimal data collection and TK/TD components for future rational screening programs.
Area of Science:
- Toxicology
- Pharmacology
- Drug Discovery
Background:
- High-throughput screening (HTS) programs in toxicology require a deep understanding of toxicokinetics and toxicodynamics (TK/TD) for accurate dose-response assessment.
- TK/TD data, typically from toxicology studies, are vital for mechanistic application in new drug selection.
- Validating novel toxicological endpoints and implementing TK/TD modeling can improve the predictive power of these screening programs.
Purpose of the Study:
- To review optimal data collection strategies for TK/TD knowledge.
- To examine the four essential components of a TK/TD knowledge base: target-specific exposure, toxicodynamics markers (with emphasis on kidney), histomorphological correlates, and human adverse event data.
- To highlight the necessity for developing new TK/TD approaches to create rational future screening programs.
Main Methods:
- Literature review focusing on optimal data collection for TK/TD.
- Analysis of the four key components of the TK/TD knowledge base.
- Discussion on the integration of TK/TD principles into HTS program design.
Main Results:
- Identified optimal approaches for collecting TK/TD data.
- Detailed the four critical components required for a comprehensive TK/TD knowledge base.
- Emphasized the need for advancements in TK/TD methodologies.
Conclusions:
- A robust TK/TD knowledge base is fundamental for designing and validating innovative HTS toxicology programs.
- Integrating target-specific exposure, toxicodynamics markers, tissue correlates, and human adverse event data is essential.
- Future drug development requires the creation of new TK/TD approaches to enhance rational screening programs.
Related Concept Videos
Toxicokinetics: Overview
Toxicity Testing in Animals
Measurement of Bioavailability: Pharmacodynamic Methods
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

